Curated Resources — Bone Density Loss risk factors associated with Aromatase Inhibitor

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Recommended deep-dive

Bone Density Loss risk factors associated with Aromatase Inhibitor: Key Facts & Context — detailed background and analysis.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.